Founded in 2012 with the pursuit of human and global health, GenBody Inc. creates innovative technologies for the development of raw materials for diagnostic use. We offer diagnostic total solutions such as rapid diagnostic tests (RDTs), fluorescent immuno-diagnostic tests, ELISA, molecular diagnostic tests (MDx), and clinical chemistry.

With over 20 years combined experience in the diagnostic industry and through vast bio-networks between several key institutes, universities, and hospitals, our core strength is in R&D. We specialize in developing monoclonal antibodies and recombinant antigens in-house at our facility in South Korea.

We also have patented technologies, including fluorescent immuno-diagnostics, which will be one of the major IVD technologies of the future.

Our mission statement is to Bring the technologies to your life.
We continuously develop innovative diagnostics and pharmaceutical technologies to improve your quality of life.

CEO of GenBody Inc.